2023
Rekindling Joy in Medicine Through Thoughtful Communication: A Practical Guide.
Sanft T, Winer E. Rekindling Joy in Medicine Through Thoughtful Communication: A Practical Guide. American Society Of Clinical Oncology Educational Book 2023, 43: e100034. PMID: 37267275, DOI: 10.1200/edbk_100034.Peer-Reviewed Original Research
2006
Inadvertent Use of Aromatase Inhibitors in Patients with Breast Cancer with Residual Ovarian Function: Cases and Lessons
Burstein H, Mayer E, Partridge A, O'Kane H, Litsas G, Come S, Hudis C, Goldstein D, Muss H, Winer E, Garber J. Inadvertent Use of Aromatase Inhibitors in Patients with Breast Cancer with Residual Ovarian Function: Cases and Lessons. Clinical Breast Cancer 2006, 7: 158-161. PMID: 16800976, DOI: 10.3816/cbc.2006.n.026.Peer-Reviewed Original ResearchConceptsResidual ovarian functionAromatase inhibitorsAI therapyBreast cancerMenopausal statusOvarian functionEarly-stage breast cancerInadvertent useChemotherapy-related amenorrheaTreatment-related amenorrheaImportant adjunctive therapyPostmenopausal womenPremenopausal womenAdjunctive therapyOvarian reserveTherapyCancerWomenAmenorrheaPatientsInhibitorsStatusCliniciansHormoneCases
2004
Oncology Physician and Nurse Practices and Attitudes Regarding Offering Clinical Trial Results To Study Participants
Partridge AH, Hackett N, Blood E, Gelman R, Joffe S, Bauer-Wu S, Knudsen K, Emmons K, Collyar D, Schilsky RL, Winer EP. Oncology Physician and Nurse Practices and Attitudes Regarding Offering Clinical Trial Results To Study Participants. Journal Of The National Cancer Institute 2004, 96: 629-632. PMID: 15100341, DOI: 10.1093/jnci/djh096.Peer-Reviewed Original ResearchConceptsTrial resultsMost patientsOncology physiciansClinical trialsClinical trial resultsOncology clinical trialsPatientsEligible membersNurses' practicePatients' difficultiesRespondersNegative emotional effectsTrialsPhysiciansFuture studiesOne-fifthParticipantsStudy resultsCancerCliniciansNursesResults of studiesEmotional effects
1999
Modeling Risk of Breast Cancer and Decisions about Genetic Testing
Parmigiani G, Berry D, Iversen E, Müller P, Schildkraut J, Winer E. Modeling Risk of Breast Cancer and Decisions about Genetic Testing. Lecture Notes In Statistics 1999, 140: 133-203. DOI: 10.1007/978-1-4612-1502-8_3.Peer-Reviewed Original ResearchBreast cancerFamily historyGenetic susceptibilityGenetic testingPreventive treatment decisionsPatient counselingRisk factorsTreatment decisionsClinical OncologyRelated cancersBRCA2 genesCancerMedical decision makingIndividualized informationRiskAccurate assessmentPatientsDuke UniversityRisk communicationBreastCliniciansEpidemiologyResearch UnitSusceptibilityOncology